Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers

References

• Baggott, M., B. Heifets, R. T. Jones, J. Mendelson, E. Sferios, and J. Zehnder. 2000. Chemical analysis of ecstasy pills. JAMA 284 (17):2190–2190.
   PubMed Web of Science ®Google Scholar
• Baggott, M. J., J. D. Siegrist, G. P. Galloway, L. C. Robertson, J. R. Coyle, and J. E. Mendelson. 2010. Investigating the mechanisms of hallucinogen-induced visions using 3, 4-methylenedioxyamphetamine (MDA): A randomized controlled trial in humans. PLoS One 5 (12):1–13. doi:10.1371/journal.pone.0014074.
   Web of Science ®Google Scholar
• Baggott, M. J., J. R. Coyle, J. D. Siegrist, K. J. Garrison, G. P. Galloway, and J. E. Mendelson. 2016a. Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting. Journal of Psychopharmacology (Oxford, England) 30:378–87. doi:10.1177/0269881115626348.
   PubMed Web of Science ®Google Scholar
• Baggott, M. J., K. J. Garrison, J. R. Coyle, G. P. Galloway, A. J. Barnes, M. A. Huestis, and J. E. Mendelson. 2016b. Mdma impairs response to water intake in healthy volunteers. Advances in Pharmacological Sciences 2016. doi: 10.1155/2016/2175896.
   PubMedGoogle Scholar
• Baker, L., and M. Taylor. 1997. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacology Biochemistry and Behavior 57 (4):737–48. doi:10.1016/S0091-3057(96)00334-6.
   PubMed Web of Science ®Google Scholar
• Bexis, S., and J. R. Docherty. 2006. Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve α‐adrenoceptors. British Journal of Pharmacology 147 (8):926–34. doi:10.1038/sj.bjp.0706688.
   PubMed Web of Science ®Google Scholar
• Brunt, T. M., and R. J. Niesink. 2011. The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison. Drug Testing and Analysis 3 (9):621–34. doi:10.1002/dta.323.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., S. Muthukumaraswamy, L. Roseman, M. Kaelen, W. Droog, K. Murphy, E. Tagliazucchi, E. E. Schenberg, T. Nest, C. Orban, et al. 2016. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences 113 (17):4853–58. doi:10.1073/pnas.1518377113.
   PubMed Web of Science ®Google Scholar
• de la Torre, R., M. Farre, P. Roset, C. H. López, M. Mas, J. Ortuno, E. Menoyo, N. Pizarro, J. Segura, and J. Cami. 2000. Pharmacology of MDMA in humans. Annals of the New York Academy of Sciences 914 (1):225–37.
   PubMed Web of Science ®Google Scholar
• de la Torre, R., M. Farre, P. N. Roset, N. Pizarro, S. Abanades, M. Segura, J. Segura, and J. Camí. 2004. Human pharmacology of MDMA: Pharmacokinetics, metabolism, and disposition. Therapeutic Drug Monitoring 26 (2):137–44.
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., J. MacKillop, M. Modi, J. Beauchemin, D. Dang, S. A. Lisman, J. K. Lum, and D. S. Wilson. 2007. Examining impulsivity as an endophenotype using a behavioral approach: A DRD2 TaqI A and DRD4 48-bp VNTR association study. Behavioral and Brain Functions : BBF 3 (2):2. doi:10.1186/1744-9081-3-2.
   PubMed Web of Science ®Google Scholar
• Jackson, B., and A. Reed. 1970. Another abusable amphetamine. JAMA 211 (5):830–830.
   PubMed Web of Science ®Google Scholar
• Kiesler, D. J. 1991. Interpersonal methods of assessment and diagnosis. In Handbook of social and clinical psychology: The health perspective, ed. C. R. Snyder and D. R. Forsyth, 438–68. Elmsford, NY: Pergamo.
   Google Scholar
• Kirkpatrick, M. G., E. W. Gunderson, A. Y. Perez, M. Haney, R. W. Foltin, and C. L. Hart. 2012. A direct comparison of the behavioral and physiological effects of methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology 219 (1):109–22. doi:10.1007/s00213-011-2383-4.
   PubMed Web of Science ®Google Scholar
• Kolbrich, E. A., R. H. Lowe, and M. A. Huestis. 2008b. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Clinical Chemistry 54 (2):379–87. doi:10.1373/clinchem.2007.096800.
   PubMed Web of Science ®Google Scholar
• Kolbrich, E. A., R. S. Goodwin, D. A. Gorelick, R. J. Hayes, E. A. Stein, and M. A. Huestis. 2008a. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Therapeutic Drug Monitoring 30 (3):320–32. doi:10.1097/FTD.0b013e3181684fa0.
   PubMed Web of Science ®Google Scholar
• Lee, M., W.-Y. Poon, and H. Kingdon. 1990. A two-phase linear regression model for biologic half-life data. The Journal of Laboratory and Clinical Medicine 115 (6):745–48.
   PubMed Web of Science ®Google Scholar
• Lyon, R. A., R. A. Glennon, and M. Titeler. 1986. 3, 4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology 88 (4):525–26.
   PubMed Web of Science ®Google Scholar
• Miliano, C., G. Serpelloni, C. Rimondo, M. Mereu, M. Marti, and M. A. De Luca. 2016. Neuropharmacology of new psychoactive substances (NPS): Focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants. Frontiers in Neuroscience 10:153. doi:10.3389/fnins.2016.00153.
   PubMed Web of Science ®Google Scholar
• Naranjo, C. 1974. The healing journey. New York, NY: Pantheon Books.
   Google Scholar
• Nash, J. F., B. L. Roth, J. D. Brodkin, D. E. Nichols, and G. A. Gudelsky. 1994. Effect of the R (−) and S (+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT 2A or 5-HT 2C receptors. Neuroscience Letters 177 (1):111–15.
   PubMed Web of Science ®Google Scholar
• Nichols, D. E. 1986. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens. Journal of Psychoactive Drugs 18 (4):305–13. doi:10.1080/02791072.1986.10472362.
   PubMed Web of Science ®Google Scholar
• Nichols, D. E., and R. Oberlender. 1990. Structure‐activity relationships of MDMA and related compounds: A new class of psychoactive drugs? Annals of the New York Academy of Sciences 600 (1):613–23.
   PubMed Web of Science ®Google Scholar
• Paton, D., J. Bell, R. Yee, and D. Cook (eds) (1975). Pharmacology and toxicity of 3, 4-methylenedioxyamphetamine, para-methoxyamphetamine and related dimethoxyamphetamines. Proceedings of the Western Pharmacology Society. Lake Tahoe, California.
   Google Scholar
• Pentney, A. R. 2001. An exploration of the history and controversies surrounding MDMA and MDA. Journal of Psychoactive Drugs 33 (3):213–21. doi:10.1080/02791072.2001.10400568.
   PubMed Web of Science ®Google Scholar
• Quinteros-Munoz, D., P. Sáez-Briones, G. Díaz-Véliz, S. Mora-Gutiérrez, M. Rebolledo-Fuentes, and B. K. Cassels. 2010. Behavioral profiles in rats distinguish among “ecstasy,” methamphetamine and 2, 5-dimethoxy-4-iodoamphetamine: Mixed effects for “ecstasy” analogues. Behavioral Neuroscience 124 (5):662. doi:10.1037/a0020827.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2014. R: A language and environment for statistical computing, R foundation for statistical computing. ISBN 3-900051-07-0: Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Rothman, R. B., M. H. Baumann, C. M. Dersch, D. V. Romero, K. C. Rice, F. I. Carroll, and J. S. Partilla. 2001. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39 (1):32–41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
   PubMed Web of Science ®Google Scholar
• Sáez-Briones, P., and A. Hernández. 2013. MDMA (3, 4-Methylenedioxymethamphetamine) analogues as tools to characterize MDMA-like effects: An approach to understand entactogen pharmacology. Current Neuropharmacology 11 (5):521. doi:10.2174/1570159X11311050007.
   PubMed Web of Science ®Google Scholar
• Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen, R., Müller, F., Borgwardt, S. and Liechti, M.E. 2014. Acute effects of lysergic acid diethylamide in healthy subjects. Biological Psychiatry 78 (8):544–553.
   PubMed Web of Science ®Google Scholar
• Setola, V., S. J. Hufeisen, K. J. Grande-Allen, I. Vesely, R. A. Glennon, B. Blough, R. B. Rothman, and B. L. Roth. 2003. 3, 4-Methylenedioxymethamphetamine (MDMA,“Ecstasy”) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro. Molecular Pharmacology 63 (6):1223–29. doi:10.1124/mol.63.6.1223.
   PubMed Web of Science ®Google Scholar
• Shulgin, A., and A. T. Shulgin. 1991. Pihkal: A chemical love story. Berkeley, CA: Transform Press. 978 plus introductory pagespp.
   Google Scholar
• Simmler, L., T. Buser, M. Donzelli, Y. Schramm, L. H. Dieu, J. Huwyler, S. Chaboz, M. C. Hoener, and M. E. Liechti. 2013. Pharmacological characterization of designer cathinones in vitro. British Journal of Pharmacology 168 (2):458–70. doi:10.1111/j.1476-5381.2012.02145.x.
   PubMed Web of Science ®Google Scholar
• Simmler, L. D., and M. E. Liechti. 2018. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances. In: New PsychoactiveSubstances. Handbook of ExperimentalPharmacology, Eds. Maurer H., Brandt S., vol 252. Cham: Springer.
   Google Scholar
• Studerus, E., A. Gamma, and F. X. Vollenweider. 2010. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5 (8):e12412–e12412. doi:10.1371/journal.pone.0012412.
   PubMed Web of Science ®Google Scholar
• Tsai, J. L., B. Knutson, and H. H. Fung. 2006. Cultural variation in affect valuation. Journal of Personality and Social Psychology 90 (2):288. doi:10.1037/0022-3514.90.2.288.
   PubMed Web of Science ®Google Scholar
• Turek, I. S., R. A. Soskin, and A. A. Kurland. 1974. Methylenedioxyamphetamine (MDA)–subjective effects. Journal of Psychoactive Drugs 6 (1):7–14.
   Google Scholar
• Vollenweider, F. X., M. F. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell. 1998. Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action. Neuroreport 9 (17):3897–902.
   PubMed Web of Science ®Google Scholar
• Weil, A. T. 1976. The love drug. Journal of Psychoactive Drugs 8 (4):335–37.
   Google Scholar
• Westfall, P. H. 1997. Multiple testing of general contrasts using logical constraints and correlations. Journal of the American Statistical Association 92 (437):299–306. doi:10.1080/01621459.1997.10473627.
   Web of Science ®Google Scholar
• Wiggins, J. S., P. Trapnell, and N. Phillips. 1988. Psychometric and geometric characteristics of the revised Interpersonal Adjective Scales (IAS-R). Multivariate Behavioral Research 23 (4):517–30. doi:10.1207/s15327906mbr2304_8.
   PubMed Web of Science ®Google Scholar
• Wiggins, J. S., and R. Broughton. 1991. A geometric taxonomy of personality scales. European Journal of Personality 5 (5):343–65. doi:10.1002/(ISSN)1099-0984.
   Web of Science ®Google Scholar
• Yensen, R., F. B. Di Leo, J. C. Rhead, W. A. Richards, R. A. Soskin, B. Turek, and A. A. Kurland. 1976. MDA-assisted psychotherapy with neurotic outpatients: A pilot study. The Journal of Nervous and Mental Disease 163 (4):233–45.
   PubMed Web of Science ®Google Scholar
• Young, R., and R. A. Glennon. 1996. A three-lever operant procedure differentiates the stimulus effects of R (-)-MDA from S (+)-MDA. Journal of Pharmacology and Experimental Therapeutics 276 (2):594–601.
   PubMed Web of Science ®Google Scholar